+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunocellular Therapeutics Ltd - logo

Immunocellular therapeutics is a cancer immunotherapy company founded in 2006 and they are headquartered in Calabasas, California. Optical Molecular Imaging, Inc. was their former name but they changed it to Immunocellular Therapeutics. Their leading product is ICT-107 which is used for the treatment of glioblastoma multiforme (GBM).

Melanocyte Protein PMEL Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Melanocyte Protein PMEL Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 87 Pages
  • Global
From
Cell Therapy Consumables Market by Type of Consumable, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical Regions: Industry Trends and Global Forecasts, 2021 - 2031 - Product Thumbnail Image

Cell Therapy Consumables Market by Type of Consumable, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical Regions: Industry Trends and Global Forecasts, 2021 - 2031

  • Report
  • August 2021
  • 234 Pages
  • Global
From
ImmunoCellular Therapeutics, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

ImmunoCellular Therapeutics, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Loading Indicator